Everly Health
PrivateLast Round
Series D
Extension
Jan 15, 2021
Est. Valuation
$1.3B
Total Funding Raised
$331M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Everly Health operates in Healthcare & Life Sciences and is based in Austin, Texas. Its latest recorded funding round was a Series D Extension round in January 2021.
Everly Health is a digital health company that provides at-home lab testing, virtual care, and diagnostic-driven health solutions for consumers and enterprise partners.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Patient Engagement, D2C Brands, Healthcare Analytics
Business Model
B2B2C
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Everly Health Comparables
Compare Everly Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| LetsGetChecked | 91% | |
| ixLayer | 80% | |
| Labcorp | 78% |
For institutional investors. Book with your work email.
Everly Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D Extension | Jan 15, 2021 | ||||
| Series D | Dec 3, 2020 | ||||
| Series C | Feb 1, 2020 | ||||
| Series B | Apr 16, 2019 | ||||
| Debt | Nov 28, 2017 | ||||
Series A | May 3, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Everly Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Goodwater Capital | Series D, Series C, Series B |
| Next Coast Ventures | Series B, Series D, Series C |
| Portfolia | Series D |
| Morningside Ventures | Series D |
| StepStone Group | Series D |
| SoGal Ventures | Series B, Series A |
| Lux Capital | Series D |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 5, 2026
Open roles increased from 0 to 895, representing 270% of headcount.
- Jul 8, 2026
Claimed #1 at-home testing company in the country.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesOct 6, 2026
Everlywell, Inc. announces the nationwide rollout and commercial availability of Clairity Breast, an AI tool that analyzes mammograms to predict five-year breast cancer risk for $249.
- hiresSep 24, 2026
Everlywell, Inc. appoints Charles Cuzzell as Chief Commercial Officer on Sep 24th '26 to accelerate enterprise expansion.
- hiresSep 24, 2026
On Sep 24th '26, Everlywell, Inc. hires Mike Considine as Chief Product Officer as it continues investing in its enterprise business.
- partners_withSep 16, 2026
On Oct 9th '26, Everlywell, Inc. and Waters Corporation partner to offer at-home HPV sample collection through health plans, with digital results and clinical follow-up.
- recognized_asSep 9, 2026
Everlywell, Inc. holds the top spot in its 2026 ranking of at-home lab test companies in the United States, citing the broadest single-brand test menu and a virtual care network that turns results into next steps, on Sep 9th '26.
For institutional investors. Book with your work email.
Everly Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Everly Health's valuation, stock price, and market status.
Is Everly Health a public or private company?
Everly Health is a private company.
What is the current stock price of Everly Health?
Everly Health is a private company, so its shares have no public market price. Caplight tracks Everly Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Everly Health worth (valuation)?
Everly Health's valuation is estimated at $1.3B based on funding round data.
Can I buy Everly Health stock?
Everly Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Everly Health's last funding round?
Everly Health's most recent funding round was Series D Extension on January 15, 2021.
Who are the main investors in Everly Health?
Key investors in Everly Health include Goodwater Capital, Highland Capital Partners, NextGen Venture Partners, HealthQuest Capital.
Will Everly Health IPO soon?
No public IPO plans have been announced for Everly Health.
How can I track Everly Health secondary market activity?
Caplight tracks bids, offers, and trades in Everly Health's shares on secondary markets.